首页> 美国卫生研究院文献>BMC Endocrine Disorders >Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized controlled multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment
【2h】

Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized controlled multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

机译:研究理由和设计eanitiate研究(Empagliflozin与NOR胰岛素的NOR胰岛素相比) - 与Empagliflozin治疗的随机控制多中心试验与新出生糖尿病患者在启动糖皮质激素治疗后的NPH-胰岛素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

EANITIATE study design flow chart. SP = Sundhedsplatformen (Electronic patient records). A complete list of study sites can be obtained from the corresponding author
机译:Enanitiate学习设计流程图。 sp = sundhedsplatformen(电子患者记录)。可以从相应的作者获得完整的学习网站列表

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号